Nasdaq

T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...
Medindia

Candida Auris: The Drug-Resistant Fungus Challenging Global Healthcare

Candida auris is a fast-spreading, drug-resistant fungus threatening hospitals worldwide, with limited treatments and urgent ...
Seeking Alpha

T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S.
Nasdaq

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida ...

LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that ...